OWEN ADAMS CATHERINE (Chief Executive Officer) sold 44.0% of their position (11.64K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $249.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001816838-26-000003
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-11.64K
Net shares
Net seller
$249.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
23.51K acquired · 35.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.51K
Price / share
—
Trade value
—
% of position
801.0%
3/24/2026
2.94K→26.44K
Common Stock
Direct
Shares
−11.64K
Price / share
$21.47
Trade value
$249.93K
% of position
44.0%
3/25/2026
26.44K→14.80K
Total
Net shares
+11.87K
Net value
-$249.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2026 | M · Option Exercise | +23.51K | — | — | 801.0% | 2.94K | 26.44K |
| Common Stock Direct | 3/25/2026 | S · Sale | −11.64K | $21.47 | $249.93K | 44.0% | 26.44K | 14.80K |
| Total | +11.87K | -$249.93K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
23.51K shares
Shares
−23.51K
Strike price
Held after
70.53K
Exercisable
—
3/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock23.51K shares | 3/24/2026 | M · Option Exercise | −23.51K | — | 70.53K |